Please contact Jörn Aldag with any inquiries.

News

Date Title
Hookipa Biotech presents positive data from Phase 1 first-in-human trial of vaccine against cytomegalovirus
Hookipa Biotech announces the appointment of Dr Reinhard Kandera as Chief Financial Officer
Hookipa Biotech announces the appointment of Igor Matushansky, M.D., Ph.D. as Global Head, Research and Development
Hookipa Biotech Announces Publication in Clinical and Vaccine Immunology Highlighting Vaxwave® as an Effective Viral Vector for Vaccination against Congenital Cytomegalovirus Infections
Hookipa Secures EUR 4.16 million Additional Grant Support from the Austrian Research Promotion Agency (FFG) to Develop Arenavirus Vector-Based Cancer Immunotherapies
Dr. Torsten Mummenbrauer Appointed SVP Business Development & Licensing of Hookipa Biotech

Events

Date Title

Bio Europe

Copenhagen, Denmark

BIO International Convention 2018

Boston, USA

4th Annual Immuno-Oncology BD&L and Investment Forum

Chicago, USA

ASCO Annual Meeting

Chicago, USA

BioEquity Europe

Ghent, Belgium

European Congress of Clinical Microbiology and Infectious Diseases

Madrid, Spain

Deutsche Biotechnologietage 2018

Berlin, Germany

Kempen Life Sciences Conference

Amsterdam, The Netherlands

World Vaccine Congress

Washington, USA

BIO-Europe Spring

Amsterdam, The Netherlands

Cowen and Co. Annual Health Care Conference

Boston, USA

LEERINK Partners 7th Annual Global Healthcare Conference

New York, USA

Immuno-Oncology 360°

New York, USA

Biotech and Money World Congress

London, UK

J.P. Morgan 36th Annual Healthcare Conference

San Francisco, USA